Dear Francesca I am pleased to send you one of the last studies New cationic nanovesicular systems containing lysine-based surfactants for topical administration: Toxicity assessment using representative skin cell lines.<http://www.ncbi.nlm.nih.gov/pubmed/23032312> Nogueira DR, Morán MC, Mitjans M, Martínez V, Pérez L, Vinardell MP. Eur J Pharm Biopharm. 2013 Jan;83(1):33-43 Best regards Pilar ------------------------------------------- Prof. Dra. M.Pilar Vinardell Directora Dep. Fisiologia Facultat de Farmacia Av. Joan XXIII s/n 08028 Barcelona (Spain) Tel: +34934024505 Fax: +34934035901 ________________________________ De: estiv-bounce@xxxxxxxxxxxxx [estiv-bounce@xxxxxxxxxxxxx] en nom de Dr Margaret Clotworthy, Human Focused Testing [margaretc@xxxxxxxxxxxxxxxxxxxxxxx] Enviat el: divendres, 24 / maig / 2013 14:53 Per a: francesca.caloni@xxxxxxxx A/c: estiv@xxxxxxxxxxxxx Tema: [estiv] Re: Reminder ESTIV Newsletter 34 Dear Francesca, Thank you for your reminder. Please include my latest review, which has just been published: Clotworthy M<http://www.ncbi.nlm.nih.gov/pubmed?term=Clotworthy%20M%5BAuthor%5D&cauthor=true&cauthor_uid=23687950>, Archibald K<http://www.ncbi.nlm.nih.gov/pubmed?term=Archibald%20K%5BAuthor%5D&cauthor=true&cauthor_uid=23687950> (2013) Advances in the development and use of human tissue-based techniques for drug toxicity testing. Expert Opin Drug Metab Toxicol.<http://www.ncbi.nlm.nih.gov/pubmed/23687950#> May 20. [Epub ahead of print] Thank you & have a good weekend! Best regards, Margaret Margaret Clotworthy PhD Director Human Focused Testing- for all your research needs HumanFocusedTesting.com TissueForResearch.com www.InVitroAssays.com Connect with me on LinkedIn: uk.linkedin.com/in/drmargaretclotworthy Quoting Francesca Caloni <francesca.caloni@xxxxxxxx>: > > Dear ESTIV members, > In June 2013 I plan to finalize the next issue of the ESTIV Newsletter. > Thank you very much to all of you who already sent me the text. > > I would like to remind everyone that I would be grateful to receive also > your latest references of publications, reports and photos from meetings, > your plans for organisation of new events etc. > > _For publications, please follow this example: > > _Selderslaghs, IWT, Blust R and Witters HE (2012) Feasibility study > of the zebrafish assay as an alternative method to screen for > developmental toxicity and embryotoxicity using a training set of 27 > compounds. Reprod Toxicol 33 (2), 142-154 > > > I am looking forward to receiving your mail not later than *May 31st > 201**3*** . > Thank you very much for your collaboration. > Kind regards, > Francesca > > -- > > Prof. Francesca Caloni DVM PhD > Università degli Studi di Milano > Department of Health, Animal Science and Food Safety > Via Celoria 10, 20133 Milan - Italy > ph ++39-02-503-17884 > fax ++39-02-503-17890 > Email:francesca.caloni@xxxxxxxx > > > -- > > Prof. Francesca Caloni DVM PhD > Università degli Studi di Milano > Department of Health, Animal Science and Food Safety > Via Celoria 10, 20133 Milan - Italy > ph ++39-02-503-17884 > fax ++39-02-503-17890 > Email: francesca.caloni@xxxxxxxx > > > > > **************** > Il 5 x mille alla nostra Università è un investimento sui giovani, > sui loro migliori progetti. > > Sostiene la libera ricerca. > Alimenta le loro speranze nel futuro. > > Investi il tuo 5 x mille sui giovani. > > Università degli Studi di Milano > codice fiscale 80012650158 > > http://www.unimi.it/13084.htm > > Aquest correu electrònic i els annexos poden contenir informació confidencial o protegida legalment i està adreçat exclusivament a la persona o entitat destinatària. Si no sou el destinatari final o la persona encarregada de rebre'l, no esteu autoritzat a llegir-lo, retenir-lo, modificar-lo, distribuir-lo, copiar-lo ni a revelar-ne el contingut. Si heu rebut aquest correu electrònic per error, us preguem que n'informeu al remitent i que elimineu del sistema el missatge i el material annex que pugui contenir. Gràcies per la vostra col·laboració. Este correo electrónico y sus anexos pueden contener información confidencial o legalmente protegida y está exclusivamente dirigido a la persona o entidad destinataria. Si usted no es el destinatario final o la persona encargada de recibirlo, no está autorizado a leerlo, retenerlo, modificarlo, distribuirlo, copiarlo ni a revelar su contenido. Si ha recibido este mensaje electrónico por error, le rogamos que informe al remitente y elimine del sistema el mensaje y el material anexo que pueda contener. Gracias por su colaboración. This email message and any documents attached to it may contain confidential or legally protected material and are intended solely for the use of the individual or organization to whom they are addressed. We remind you that if you are not the intended recipient of this email message or the person responsible for processing it, then you are not authorized to read, save, modify, send, copy or disclose any of its contents. If you have received this email message by mistake, we kindly ask you to inform the sender of this and to eliminate both the message and any attachments it carries from your account. Thank you for your collaboration.